Tyrosine phosphorylation of caveolin 1 by oxidative stress is reversible and dependent on the c-src tyrosine kinase but not mitogen-activated protein kinase pathways in placental artery endothelial cells

Biology of Reproduction

Volumn 73, Issue 4, 2005, Pages 761-772

  Chen, Dong Bao ^a   Li, Su Min ^a   Qian, Xiao Xian ^a,c   Moon, ChongSoo ^a,d   Zheng, Jing ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

^d Hallym University   (South Korea)

Author keywords

Caveolin 1; Kinases; Oxidative stress; Placenta; Placental artery endothelial cells; Pregnancy; Signal transduction; Stress; Tyrosine phosphorylation

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CATALASE; CAVEOLIN 1; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE 1; SUPEROXIDE DISMUTASE; TYROSINE;

ACTIN FILAMENT; ANIMAL CELL; ARTERY; ARTERY ENDOTHELIUM; ARTICLE; CELL SHAPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLOGY; ENZYME ACTIVATION; ENZYME MECHANISM; FEMALE; NONHUMAN; ONCOGENE SRC; OXIDATIVE STRESS; PLACENTA; PLACENTA ARTERY; PREGNANCY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SHEEP; TIME;

ANIMALS; ANTIOXIDANTS; ARTERIES; CAVEOLIN 1; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; HYDROGEN PEROXIDE; MAP KINASE SIGNALING SYSTEM; OXIDATIVE STRESS; PHOSPHORYLATION; PLACENTA; PREGNANCY; PROTEIN-TYROSINE KINASES; SHEEP; TYROSINE;

EID: 25144489481     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.105.040881     Document Type: Article

References (64)

1. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 1998; 273:5419-5422.
2. Glenney JR Jr, Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci U S A 1992; 89:10517-10521.
3. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 1999; 19:7289-7304.
4. Predescu D, Palade GE. Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am J Physiol 1993; 265:H725-733.
5. Predescu SA, Predescu DN, Palade GE. Plasmalemmal vesicles function as transcytotic carriers for small proteins in the continuous endothelium. Am J Physiol 1997; 272:H937-949.
6. Anderson RG, Kamen BA, Rothberg KG, Lacey SW. Potocytosis: sequestration and transport of small molecules by caveolae. Science 1992; 255:410-411.
7. Navarro A, Anand-Apte B, Parat MO. A role for caveolae in cell migration. FASEB J 2004; 18:1801-1811.
8. Frank PG, Woodman SE, Park DS, Lisanti MP. Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol 2003; 23:1161-1168.
9. Li S, Seitz R, Lisanti MP. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem 1996; 271:3863-3868.
10. Volonte D, Galbiati F, Pestell RG, Lisanti MP. Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr(14)) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress. J Biol Chem 2001; 276:8094-8103.
11. Sanguinetti AR, Mastick CC. c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14. Cell Signal 2003; 15:289-298.
12. Cao H, Sanguinetti AR, Mastick CC. Oxidative stress activates both Src-kinases and their negative regulator Csk and induces phosphorylation of two targeting proteins for Csk: caveolin-1 and paxillin. Exp Cell Res 2004; 294:159-171.
13. Maggi D, Biedi C, Segat D, Barbero D, Panetta D, Cordera R. IGF-I induces caveolin 1 tyrosine phosphorylation and translocation in the lipid rafts. Biochem Biophys Res Commun 2002; 295:1085-1089.
14. Fielding PE, Chau P, Liu D, Spencer TA, Fielding CJ. Mechanism of platelet-derived growth factor-dependent caveolin-1 phosphorylation: relationship to sterol binding and the role of serine-80. Biochemistry 2004; 43:2578-2586.
15. Kim YN, Wiepz GJ, Guadarrama AG, Bertics PJ. Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status. J Biol Chem 2000; 275:7481-7491.
16. Labrecque L, Royal I, Surprenant DS, Patterson C, Gingras D, Beliveau R. Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell 2003; 14:334-347.
17. Parat MO, Anand-Apte B, Fox PL. Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions. Mol Biol Cell 2003; 14:3156-3168.
18. Fridovich I. Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann N Y Acad Sci 1999; 893:13-18.
19. Yoon SO, Yun CH, Chung AS. Dose effect of oxidative stress on signal transduction in aging. Mech Ageing Dev 2002; 123:1597-1604.
20. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999; 85:753-766.
21. Willcox JK, Ash SL, Catignani GL. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004; 44:275-295.
22. Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett 1995; 369:131-135.
23. Lyall F, Gibson JL, Greer IA, Brockman DE, Eis AL, Myatt L. Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care 1998; 21:1753-1758.
24. Myatt L, Kossenjans W, Sahay R, Eis A, Brockman D. Oxidative stress causes vascular dysfunction in the placenta. J Matern Fetal Med 2000; 9:79-82.
25. Bilodeau JF, Hubel CA. Current concepts in the use of antioxidants for the treatment of preeclampsia. J Obstet Gynaecol Can 2003; 25:742-750.
26. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004; 122:369-382.
27. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204.
28. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222:222-235.
29. Myatt L. Role of placenta in preeclampsia. Endocrine 2002; 19:103-111.
30. Zygmunt M. Placental circulation: clinical significance. Early Pregnancy 2001; 5:72-73.
31. Roberts JM, Hubel CA. Oxidative stress in preeclampsia. Am J Obstet Gynecol 2004; 190:1177-1178.
32. Little RE, Gladen BC. Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol 1999; 13:347-352.
33. Zheng J, Bird IM, Melsaether AN, Magness RR. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 1999; 140:1399-1407.
34. Chen DB, Westfall SD, Fong HW, Roberson MS, Davis JS. Prostaglandin F2alpha stimulates the Raf/MEK1/mitogen-activated protein kinase signaling cascade in bovine luteal cells. Endocrinology 1998; 139:3876-3885.
35. Chen DB, Zangl AL, Zhao Q, Markley JL, Zheng J, Bird IM, Magness RR. Ovine caveolin-1: cDNA cloning, E. coli expression, and association with endothelial nitric oxide synthase. Mol Cell Endocrinol 2001; 175:41-56.
36. Chen DB, Bird IM, Zheng J, Magness RR. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 2004; 145:113-125.
37. Kim YN, Dam P, Bertics PJ. Caveolin-1 phosphorylation in human squamous and epidermoid carcinoma cells: dependence on ErbB1 expression and Src activation. Exp Cell Res 2002; 280:134-147.
38. Liao WX, Magness RR, Chen DB. Expression of estrogen receptors-alpha and -beta in the pregnant ovine uterine artery endothelial cells in vivo and in vitro. Biol Reprod 2005; 72:530-537.
39. Faulstich H, Trischmann H, Mayer D. Preparation of tetramethylrhodaminyl- phalloidin and uptake of the toxin into short-term cultured hepatocytes by endocytosis. Exp Cell Res 1983; 144:73-82.
40. Blanc A, Pandey NR, Srivastava AK. Synchronous activation of ERK 1/2, p38mapk and PKB/Akt signaling by H2O2 in vascular smooth muscle cells: potential involvement in vascular disease (review). Int J Mol Med 2003; 11:229-234.
41. Sargiacomo M, Scherer PE, Tang ZL, Casanova JE, Lisanti MP. In vitro phosphorylation of caveolin-rich membrane domains: identification of an associated serine kinase activity as a casein kinase II-like enzyme. Oncogene 1994; 9:2589-2595.
42. Reynolds LP, Redmer DA. Angiogenesis in the placenta. Biol Reprod 2001; 64:1033-1040.
43. Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: key pieces of the development puzzle. Science 1994; 266:1508-1518.
44. Roberts JM, Speer P. Antioxidant therapy to prevent preeclampsia. Semin Nephrol 2004; 24:557-564.
45. Palade GE. An electron microscope study of the mitochondrial structure. J Histochem Cytochem 1953; 1:188-211.
46. Yamada E. The fine structure of the renal glomerulus of the mouse. J Biophys Biochem Cytol 1955; 1:551-566.
47. McGuire PG, Twietmeyer TA. Transcytosis of ferritin and increased production of subendothelial matrix components by aortic endothelial cells during the development of hypertension. Microcirc Endothelium Lymphatics 1985; 2:129-149.
48. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 2004; 84:1341-1379.
49. Minshall RD, Tiruppathi C, Vogel SM, Malik AB. Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol 2002; 117:105-112.
50. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001; 276:38121-38138.
51. Dupree P, Parton RG, Raposo G, Kurzchalia TV, Simons K. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J 1993; 12:1597-1605.
52. Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 2002; 64:749-774.
53. Govers R, van der Sluijs P, van Donselaar E, Slot JW, Rabelink TJ. Endothelial nitric oxide synthase and its negative regulator caveolin-1 localize to distinct perinuclear organelles. J Histochem Cytochem 2002; 50:779-788.
54. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30:1191-1212.
55. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000; 279:L1005-1028.
56. de Vries J, Verboom CN. Effects of scavengers of superoxide radicals, hydrogen peroxide, singlet oxygen and hydroxyl radicals on malondialdehyde generation from arachidonic acid by bovine seminal vesicle microsomes. Experientia 1980; 36:1339-1340.
57. Drost E, Lannan S, Bridgeman MM, Brown D, Selby C, Donaldson K, MacNee W. Lack of effect of N-acetylcysteine on the release of oxygen radicals from neutrophils and alveolar macrophages. Eur Respir J 1991; 4:723-729.
58. Ding M, Li JJ, Leonard SS, Ye JP, Shi X, Colburn NH, Castranova V, Vallyathan V. Vanadate-induced activation of activator protein-1: role of reactive oxygen species. Carcinogenesis 1999; 20:663-668.
59. Gonzalez-Rubio M, Voit S, Rodriguez-Puyol D, Weber M, Marx M. Oxidative stress induces tyrosine phosphorylation of PDGF alpha- and beta-receptors and pp60c-src in mesangial cells. Kidney Int 1996; 50:164-173.
60. Abe J, Takahashi M, Ishida M, Lee JD, Berk BC. c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J Biol Chem 1997; 272:20389-20394.
61. Zheng J, Wen Y, Chen DB, Bird IM, Magness RR. Angiotensin ii elevates nitric oxide synthase 3 expression and nitric oxide production via a mitogen-activated protein kinase cascade in ovine fetoplacental artery endothelial cells. Biol Reprod 2005; 72:1421-1428.
62. Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, Gopal S, Shen MM. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci U S A 2000; 97:10454-10459.
63. Walsh SW, Wang Y. Deficient glutathione peroxidase activity in pre-eclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol 1993; 169:1456-1461.
64. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53-56.